naringenin has been researched along with Hypoxia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Banu Doğanlar, Z; Doğanlar, O; Kurtdere, K; Özcan, H; Zaim, Ö; Zreigh, MM | 1 |
Ajayi, AM; Bakre, AG; Ben-Azu, B; Femi-Akinlosotu, O; Olugbemide, AS; Umukoro, S | 1 |
Ganesan, K; Kathiresan, V; Krishna, AV; Natarajan, M; Ramachandran, M; Rathinasamy, G; Subburaman, S | 1 |
3 other study(ies) available for naringenin and Hypoxia
Article | Year |
---|---|
Novel synthesis naringenin-benzyl piperazine derivatives prevent glioblastoma invasion by inhibiting the hypoxia-induced IL6/JAK2/STAT3 axis and activating caspase-dependent apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Glioblastoma; Humans; Hypoxia; Interleukin-6; Janus Kinase 2; Piperazines; STAT3 Transcription Factor | 2022 |
Naringenin improves depressive- and anxiety-like behaviors in mice exposed to repeated hypoxic stress through modulation of oxido-inflammatory mediators and NF-kB/BDNF expressions.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain; Brain-Derived Neurotrophic Factor; Catalase; Corticosterone; Depression; Flavanones; Glutathione; Hypoxia; Inflammation; Interleukin-1beta; Male; Malondialdehyde; Mice; Motor Activity; NF-kappa B; Nitric Oxide Synthase Type II; Oxidative Stress; Tumor Necrosis Factor-alpha | 2021 |
Naringenin Ameliorates Doxorubicin Toxicity and Hypoxic Condition in Dalton's Lymphoma Ascites Tumor Mouse Model: Evidence from Electron Paramagnetic Resonance Imaging.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Carcinoma, Ehrlich Tumor; Doxorubicin; Electron Spin Resonance Spectroscopy; Enzyme Activation; Flavanones; Hypoxia; Lipid Peroxidation; Mice; Oxidoreductases; Pyrrolidines; Random Allocation | 2016 |